BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18265946)

  • 21. Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling.
    Wei XM; Wumaier G; Zhu N; Dong L; Li CW; Xia JW; Zhang YZ; Zhang P; Zhang XJ; Zhang YY; Li SQ
    Acta Pharmacol Sin; 2020 Aug; 41(8):1102-1110. PubMed ID: 32152438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
    Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
    Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.
    Abaan OD; Levenson A; Khan O; Furth PA; Uren A; Toretsky JA
    Oncogene; 2005 Apr; 24(16):2715-22. PubMed ID: 15782144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution crystal structure of the PDZ1 domain of human protein tyrosine phosphatase PTP-Bas.
    Lee SO; Lee MK; Ku B; Bae KH; Lee SC; Lim HM; Kim SJ; Chi SW
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1205-10. PubMed ID: 27544031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis.
    Cuppen E; Nagata S; Wieringa B; Hendriks W
    J Biol Chem; 1997 Nov; 272(48):30215-20. PubMed ID: 9374505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methylation Status of PTPL1 Gene in Non-Hodgkin's Lymphoma Cells].
    Wang WM; Wang J; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1596-600. PubMed ID: 26708878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas.
    Saras J; Engström U; Góñez LJ; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):20979-81. PubMed ID: 9261095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protein tyrosine phosphatase PTP-Basophil/Basophil-like. Interacting proteins and molecular functions.
    Erdmann KS
    Eur J Biochem; 2003 Dec; 270(24):4789-98. PubMed ID: 14653806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1.
    Saras J; Franzén P; Aspenström P; Hellman U; Gonez LJ; Heldin CH
    J Biol Chem; 1997 Sep; 272(39):24333-8. PubMed ID: 9305890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma.
    Wang W; Wang J; Li M; Ying J; Jing H
    Int J Mol Med; 2015 Sep; 36(3):698-704. PubMed ID: 26133246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein tyrosine phosphatase L1 inhibits high-grade serous ovarian carcinoma progression by targeting IκBα.
    Wang Y; Li M; Huang T; Li J
    Onco Targets Ther; 2018; 11():7603-7612. PubMed ID: 30464509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-specific 1H, 13C, and 15N assignment of the extended PDZ3 domain of the protein tyrosine phosphatase basophil-like PTP-BL.
    Kock G; Dicks M; Heumann R; Erdmann KS; Stoll R
    Biomol NMR Assign; 2010 Oct; 4(2):199-202. PubMed ID: 20563762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding affinity of PTPN13's tandem PDZ2/3 domain is allosterically modulated.
    Dicks M; Kock G; Kohl B; Zhong X; Pütz S; Heumann R; Erdmann KS; Stoll R
    BMC Mol Cell Biol; 2019 Jul; 20(1):23. PubMed ID: 31286859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Basis of Class III Ligand Recognition by PDZ3 in Murine Protein Tyrosine Phosphatase PTPN13.
    Kock G; Dicks M; Yip KT; Kohl B; Pütz S; Heumann R; Erdmann KS; Stoll R
    J Mol Biol; 2018 Oct; 430(21):4275-4292. PubMed ID: 30189200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
    Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
    Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13.
    Sotelo NS; Schepens JT; Valiente M; Hendriks WJ; Pulido R
    Methods; 2015 May; 77-78():147-56. PubMed ID: 25448478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.
    Zhu JH; Chen R; Yi W; Cantin GT; Fearns C; Yang Y; Yates JR; Lee JD
    Oncogene; 2008 Apr; 27(18):2525-31. PubMed ID: 17982484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour suppressor function of protein tyrosine phosphatase receptor-T.
    Scott A; Wang Z
    Biosci Rep; 2011 Oct; 31(5):303-7. PubMed ID: 21517784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protein tyrosine phosphatase-BL, modulates pancreatic beta-cell proliferation by interaction with the Wnt signalling pathway.
    Welters HJ; Oknianska A; Erdmann KS; Ryffel GU; Morgan NG
    J Endocrinol; 2008 Jun; 197(3):543-52. PubMed ID: 18413347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence-specific (1)H, (13)C, and (15)N backbone assignment of the 28 kDa PDZ2/PDZ3 tandem domain of the protein tyrosine phosphatase PTP-BL.
    Fetzer CP; Sauvageau J; Kock G; Berghaus C; Bangert JA; Dicks M; Heumann R; Erdmann KS; Stoll R
    Biomol NMR Assign; 2007 Dec; 1(2):151-3. PubMed ID: 19636852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.